effects of semaglutide on kidneys semaglutide, empagliflozin and their combination renal diffusion-weighted MRI and total kidney volume in patients with type 2 diabetes: a post hoc analysis from a 32 week randomised trial Patients with type 2 diabetes
Description
Lymphoma remissions caused by anti-CD19 chimeric antigen receptor T cells are associated with high serum interleukin-15 levels
GIP/GLP-1InkretinMetabolismusDual-Agonist Tirzepatide 5 mg was du wissen solltest Tirzepatide ist ein synthetisches 39-Aminosuren-Peptid und der erste seiner Klasse als dualer Agonist an den Rezeptoren des glukoseabhngigen insulinotropen Polypeptids ( GIP ) und des Glucagon-hnlichen Peptids-1 ( GLP-1 )
Practical approach to SGLT2 inhibitors for treatment of cardiovascular disease
Theme 3: Off-Label Use in Type 1 Diabetes (T1D) Although GLP-1s are not approved for people with T1D, some individuals with T1D are using them off-label, particularly if they live with obesity, strong insulin resistance, or significant post-meal blood sugar spikes
